ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.

Razan Masarwy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.